Professor, Urology, University of Wisconsin Medical School
Urology
Dr. David F. Jarrard, MD
|
|
Give Review
David Jarrard is an expert in the field of Urology. He went to medical school at University of Virginia School of Medicine. He received 2 awards: "Regional Top Doctor" and "Meaningful Use Stage 1 Certification". David Jarrard is also a published doctor. He has 94 publication published. The most recent publication is: Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. He accepts all Medicare patients.
Publications
- Prostate Cancer: The applicability of textural analysis of MRI for grading.
- Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer.
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
- Pyrosequencing for Accurate Imprinted Allele Expression Analysis.
- The epigenetics of prostate Cancer diagnosis and prognosis: update on clinical applications.
- Androgen receptor DNA methylation regulates the timing and androgen sensitivity of mouse Prostate ductal development.
- Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer.
- Potential Role for Androgen-Deprivation Therapy and Pelvic Radiation Therapy in Node-Positive Postprostatectomy Prostate Cancer.
- Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?
- Novel Fusion Transcripts Associate with Progressive Prostate Cancer.
- Analysis and validation of tissue biomarkers for Renal cell carcinoma using automated high-throughput evaluation of protein expression.
- Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate Cancer.
- Epigenetic susceptibility factors for prostate Cancer with aging.
- Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate Cancer.
- Androgen deprivation induces senescence characteristics in prostate Cancer cells in vitro and in vivo.
- Analysis of promoter non-CG methylation in prostate Cancer.
- Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1?-hydroxyvitamin D2 in patients with clinically localized prosta...
- CpG Island Hypermethylation Frequently Silences FILIP1L Isoform 2 Expression in Prostate Cancer.
- Employing the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy-Negative Patients.
- Analysis of urological procedures in men who died from prostate Cancer using a population-based approach.
- Towards the Detection of Prostate Cancer in Urine: A Critical Analysis.
- Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate Cancer.
- Even-skipped homeobox 1 is frequently hypermethylated in prostate Cancer and predicts PSA recurrence.
- The Development of an eHealth Tool Suite for Prostate Cancer Patients and Their Partners.
- Phase III Trial of Selenium to Prevent Prostate Cancer in Men with High-grade Prostatic Intraepithelial Neoplasia: SWOG S9917.
- Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate Cancer.
- Early hypofractionated salvage radiotherapy for postProstatectomy biochemical recurrence.
- Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing Cancer.
- Therapy-induced senescence in Cancer.
- Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the Prostate.
- Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation.
- Current prostate biopsy protocols cannot reliably identify patients for focal therapy: correlation of low-risk prostate Cancer on biopsy with radical prostatectomy fin...
- Robotic-assisted laparoscopic and radical retropubic Prostatectomy generate similar positive margin rates in low and intermediate risk patients.
- A high-throughput method to identify novel senescence-inducing compounds.
- Flexible and rigid cystoscopy in women.
- Aging and Cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
- A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the Prostate.
- Salvage hypofractionated radiotherapy for biochemically recurrent prostate Cancer after radical prostatectomy.
- Management of prostate Cancer recurrences after radiation therapy-brachytherapy as a salvage option.
- Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open Prostatectomy.
- Adjuvant weekly docetaxel for patients with high risk prostate Cancer after radical prostatectomy: a multi-institutional pilot study.
- The expanding role of epigenetics in the development, diagnosis and treatment of prostate Cancer and benign prostatic hyperplasia.
- High dose zinc increases hospital admissions due to genitourinary complications.
- Health perceptions in patients who undergo screening and workup for prostate Cancer.
- Resveratrol-caused apoptosis of human Prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
- A novel biomarker for staging human Prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator in...
- p16 Is upregulated in proliferative inflammatory atrophy of the Prostate.
- The identification of senescence-specific genes during the induction of senescence in prostate Cancer cells.
- Modulation of CXCL14 (BRAK) expression in prostate Cancer.
- Does zinc supplementation increase the risk of prostate Cancer?
- Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic Cancers after high-dose radiation.
- A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells.
- Extension of a shortened ureter using the in situ appendix during Indiana pouch urinary diversion.
- Cdc37 enhances proliferation and is necessary for normal human Prostate epithelial cell survival.
- Pyoderma gangrenosum of penis.
- Resection of isolated fossa recurrence of Renal-cell carcinoma after nephrectomy using hand-assisted laparoscopy.
- Novel pathways associated with bypassing cellular senescence in human Prostate epithelial cells.
- Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic Prostatectomy.
- A Novel Pathway Links Oxidative Stress to Loss of Insulin Growth Factor-2 (IGF2) Imprinting through NF-κB Activation.
- Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human Prostate epithelial and uroepithelial cells.
- Hand-assisted laparoscopic radical nephrectomy: comparison to open radical nephrectomy.
- Indiana pouch urinary diversion for adenocarcinoma developing after ureterosigmoidostomy.
- Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human Bladder cancers.
- Methylation of the androgen receptor minimal promoter silences transcription in human prostate Cancer.
- More data on locally extensive prostate Cancer--betting on the margin.
- Screening hypermethylated regions by methylation-sensitive single-strand conformational polymorphism.
- p16/pRb pathway alterations are required for bypassing senescence in human Prostate epithelial cells.
- Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate Cancer cells.
- Regional loss of imprinting of the insulin-like growth factor II gene occurs in human Prostate tissues.
- P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate Cancer.
- Overcoming cellular senescence in human Cancer pathogenesis.
- Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate Cancer.
- The cadherin cell-cell adhesion pathway in prostate Cancer progression.
- Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate Cancer.
- DNA methylation, molecular genetic, and linkage studies in prostate Cancer.
- Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.
- Effect of epidermal growth factor on prostate Cancer cell line PC3 growth and invasion.
- Urokinase plasminogen activator is necessary but not sufficient for prostate Cancer cell invasion.
- Ureteroscopic endopyelotomy in an ectopic Kidney.
- E-cadherin expression is silenced by DNA hypermethylation in human breast and Prostate carcinomas.
- Prostate Cancer staging after radiation utilizing laparoscopic pelvic lymphadenectomy.
- Robotic assisted laparoscopic radical Prostatectomy: evolution and outcomes.
- Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate Cancer: a tissue microarray and automated quantitative analysis.
- A technique for the management of a large median lobe in robot-assisted laparoscopic radical Prostatectomy.
- Transabdominal preperitoneal robotic inguinal hernia repair.
- Clinical problem-solving. An unintended consequence--a 79-year-old man with a 5-month history of fatigue and 20-lb (9-kg) weight loss presented to his local physician.
- Design and progress of a trial of selenium to prevent prostate Cancer among men with high-grade prostatic intraepithelial neoplasia.
- Common ground: hospitals, physicians and outpatient centers.
- Pennington scientific symposium on mechanisms and retardation of aging.
- Sonographically documented stable seminoma: a case report.
- Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
- Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate Cancer.
- Reduced Bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
Schools
Virginia Commonwealth University School Of Medicine
University Of Chicago Hosps
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- Orchiectomy
- View All
Conditions Treated
- Bladder Atony
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Chicago -
University of Virginia School of Medicine
Hospital
-
University of Wisconsin Hospital and Clinics
Drug Facts
| NPI NUMBER | 1467416024 | |
| NPPES Provider LastName | JARRARD | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 53792 | |
| NPPES Provider State | WI | |
| Specialty Description | Urology | |
| Total Claim Count | 414.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 6.04 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467416024 |
| Last Name Of The Provider | JARRARD |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Aaron M. Johnson, SLP
 This Doctor is OpenDoctor Recommended.
|
|
|
Mark E. Wakefield, MA
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. McAchran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Earl B. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gholam H. Malek, MD |
|
|
Dr. Arthur C. Plautz Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dan R. Gralnek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Blute, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sriharan Sivalingam, MD |
|
|
Dr. Stephen Y. Nakada, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John J. McGetrick Jr., MD |
|
|
Dr. Necole M. Streeper, MD
This Doctor is OpenDoctor Recommended.
|